Literature DB >> 19683446

Neurosurgery for obsessive-compulsive disorder: contemporary approaches.

Renee E Bear1, Paul Fitzgerald, Jeffrey V Rosenfeld, Richard G Bittar.   

Abstract

Surgery for psychiatric disorders has a controversial history. Traditionally, procedures were undertaken to physically disconnect or destroy certain areas of the brain thought to constitute critical components of the limbic pathways. The relatively recent advent of the much safer and non-destructive technique known as deep brain stimulation has coincided with a resurgence in interest in psychosurgery. Contemporary approaches to the surgical management of obsessive-compulsive disorder are discussed, together with our current understanding of its pathophysiology. Copyright (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19683446     DOI: 10.1016/j.jocn.2009.02.043

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  2 in total

1.  Operationalizing Cognitive Science and Technologies' Research and Development; the "Brain and Cognition Study Group (BCSG)" Initiative from Shiraz, Iran.

Authors:  Nahid Ashjazadeh; Reza Boostani; Hamed Ekhtiari; Masoumeh Emamghoreishi; Majidreza Farrokhi; Ahmad Ghanizadeh; Gholamreza Hatam; Habib Hadianfard; Mehrzad Lotfi; Seyed Mohammad Javad Mortazavi; Maryam Mousavi; Afshin Montakhab; Majid Nili; Ali Razmkon; Sina Salehi; Amir Mohammad Sodagar; Peiman Setoodeh; Mousa Taghipour; Mohammad Torabi-Nami; Abdolkarim Vesal
Journal:  Basic Clin Neurosci       Date:  2014

2.  Identification of biomarkers that predict response to subthalamic nucleus deep brain stimulation in resistant obsessive-compulsive disorder: protocol for an open-label follow-up study.

Authors:  Shyam Sundar Arumugham; Dwarakanath Srinivas; Janardhanan C Narayanaswamy; T S Jaisoorya; Himani Kashyap; Philippe Domenech; Stéphane Palfi; Luc Mallet; Ganesan Venkatasubramanian; Yc Janardhan Reddy
Journal:  BMJ Open       Date:  2021-06-22       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.